VINTAFECT

Serial Number 98800120
641

Registration Progress

Application Filed
Oct 14, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

VINTAFECT

Basic Information

Serial Number
98800120
Filing Date
October 14, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Apr 24, 2025
Application
Pending
Classes
040 042

Rights Holder

Vintabio, Inc.

03
Address
4050 S. 26th St., Suite 200
Philadelphia, PA 19102

Ownership History

Vintabio, Inc.

Original Applicant
03
Philadelphia, PA

Legal Representation

Attorney
Julia M. Chester

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Jul 24, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jul 24, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Apr 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 24, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 24, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 16, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 15, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 14, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 040
Manufacturing services for others in the field of biologics; manufacturing services for others in the field of transient transfection technology; biomanufacturing for others, namely, manufacturing of gene therapy products using biological organisms in the manufacturing process; cell therapy manufacturing for others; providing technical information in the field of pharmaceutical manufacturing; biomanufacturing of viral vectors and gene therapy vectors; biomanufacturing services of cell lines and cells
First Use Anywhere: 20231100
First Use in Commerce: 20231100
Class 042
Product research and development in the fields of biology and medical sciences; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of biologics; pharmaceutical drug and biologics delivery technology development services, namely, research and development in the area of pharmaceutical drug and biologics delivery systems in the nature of viral vectors; biological research and analysis; consulting services in the fields of research and development of biologics; scientific and technological services, namely, scientific research, analysis and testing in the field of biological vectors; scientific research services in the field of cell modification; pharmaceutical research services, namely, protein and cell line development and production; genetic engineering services utilizing a collection of genetic technologies for the rapid production of cell lines; scientific, laboratory and medical research in the field of cell line engineering; scientific laboratories performing cell line development; scientific research and development, namely, development of cell lines and proteins for others
First Use Anywhere: 20231100
First Use in Commerce: 20231100

Classification

International Classes
040 042